AbbVie Inc (ABBV)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Richard A. Gonzalez
Employees:
30,000
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL 60064
(847) 932-7900

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.

Data derived from most recent annual or quarterly report
Market Cap 241.714 Billion Shares Outstanding1.767 Billion Avg 30-day Volume 6.863 Million
P/E Ratio29.3371 Dividend Yield4.5065 EPS1.78
Price to Revenue3.6381 Debt to Equity6.522 EBITDA17.261 Billion
Price to Book Value15.552 Operating Margin28.945300000000003 Enterprise Value268.77 Billion
Current Ratio0.906 EPS Growth-0.24 Quick Ratio0.645
1 Yr BETA 0.5695 52-week High/Low 137.98 / 97.28 Profit Margin12.4235
Operating Cash Flow Growth38.8014 Altman Z-Score1.404 Free Cash Flow to Firm 27.269 Billion
View SEC Filings from ABBV instead.

View recent insider trading info

Funds Holding ABBV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABBV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

426.5 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

413.3 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RAPP EDWARD J

  • Director
21,434 2021-12-31 5

LIDDY EDWARD M

  • Director
28,024 2021-12-31 5

STROM CARRIE C SVP & PRES GLOBAL ALLERG AESTH

  • Officer
40,711 2021-12-31 8

SEVERINO MICHAEL VICE CHAIRMAN

  • Officer
103,252 2021-12-27 3

SCHUMACHER LAURA J VICE CHAIRMAN

  • Officer
197,098 2021-12-21 5

DURKIN BRIAN L VP, CONTROLLER

  • Officer
16,505 2021-12-20 3

STEWART JEFFREY RYAN EVP, CHIEF COMMERCIAL OFFICER

  • Officer
48,442 2021-12-15 4

SORG ELAINE K. SVP, US COMMERCIAL OPERATIONS

  • Officer
0 2021-12-10 5

GONZALEZ RICHARD A CHAIRMAN OF THE BOARD AND CEO

  • Officer
  • Director
487,162 2021-12-09 3

RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER

  • Officer
0 2021-12-06 3

AUSTIN ROXANNE S

  • Director
49,284 2021-11-02 2

ALPERN ROBERT J

  • Director
8,068 2021-09-30 4

GOSEBRUCH HENRY O EVP, CHIEF STRATEGY OFFICER

  • Officer
100,500 2021-09-07 3

SALEKI-GERHARDT AZITA EVP, OPERATIONS

  • Officer
122,429 2021-05-24 3

TILTON GLENN F

  • Director
46,518 2021-05-07 1

WADDELL FREDERICK H

  • Director
23,562 2021-05-07 1

FREYMAN THOMAS C

  • Director
127,296 2021-05-07 1

ROBERTS REBECCA B

  • Director
8,332 2021-05-07 1

HART BRETT J

  • Director
14,076 2021-05-07 1

BURNSIDE WILLIAM H.L.

  • Director
21,562 2021-05-07 1

MEYER MELODY B

  • Director
11,102 2021-05-07 1

MICHAEL ROBERT A. EVP, CHIEF FINANCIAL OFFICER

  • Officer
37,877 2021-02-28 2

HUDSON THOMAS J SVP, R&D AND CSO

  • Officer
29,372 2021-02-28 2

ALBAN CARLOS VICE CHAIRMAN

  • Officer
155,341 2020-11-16 0

DONOGHOE NICHOLAS SVP, ENTERPRISE INNOVATION

  • Officer
15,149 2020-02-28 0

CHASE WILLIAM J EVP, FINANCE & ADMINISTRATION

  • Officer
170,053 2019-06-26 0

HURWICH THOMAS A. VP, CONTROLLER

  • Officer
No longer subject to file 2017-02-28 0

ROBERTS ROY S

  • Director
27,486 2015-05-08 0

LEONARD JOHN M. SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
113,793 2013-03-15 0

ABBOTT LABORATORIES

  • 10% Owner
0 2012-12-12 0

LINDER GREG W

  • Director
0 2012-12-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2022-01-05 17:27:09 -0500 2021-12-31 F 10,336 $135.93 d 40,711 direct -0.2588 -0.2398 1.5234 5 -0.2588 2

RAPP EDWARD J - Director

2022-01-04 17:02:41 -0500 2021-12-31 A 260 $135.40 a 21,434 direct

LIDDY EDWARD M - Director

2022-01-04 17:03:37 -0500 2021-12-31 A 212 $135.40 a 28,024 direct

SEVERINO MICHAEL - Officer VICE CHAIRMAN

2021-12-30 17:01:25 -0500 2021-12-27 G 583 d 103,252 direct 0.0148 -0.384 0.3471 4 -0.384 6

SCHUMACHER LAURA J - Officer VICE CHAIRMAN

2021-12-23 17:01:38 -0500 2021-12-21 G 15,905 d 197,098 direct -0.0149 0.7514 1.1309 4 -0.0149 2

DURKIN BRIAN L - Officer VP, CONTROLLER

2021-12-21 17:29:21 -0500 2021-12-20 S 11,790 $128.51 d 16,505 direct 0.7876 2.9383 2.9383 6 0.0 1

DURKIN BRIAN L - Officer VP, CONTROLLER

2021-12-21 17:29:21 -0500 2021-12-20 M 7,180 $61.36 a 28,295 direct 0.7876 2.9383 2.9383 6 0.0 1

DURKIN BRIAN L - Officer VP, CONTROLLER

2021-12-21 17:29:21 -0500 2021-12-20 M 7,180 $61.36 d 0 direct

SCHUMACHER LAURA J - Officer VICE CHAIRMAN

2021-12-21 17:21:11 -0500 2021-12-17 M 103,220 $58.88 d 0 direct

SCHUMACHER LAURA J - Officer VICE CHAIRMAN

2021-12-21 17:21:11 -0500 2021-12-17 M 103,220 $58.88 a 316,223 direct 0.7876 2.9383 2.9383 6 0.0 1

SCHUMACHER LAURA J - Officer VICE CHAIRMAN

2021-12-21 17:21:11 -0500 2021-12-17 S 4,114 $130.61 d 213,003 direct 0.7876 2.9383 2.9383 6 0.0 1

SCHUMACHER LAURA J - Officer VICE CHAIRMAN

2021-12-21 17:21:11 -0500 2021-12-17 S 177,556 $130.23 d 217,117 direct 0.7876 2.9383 2.9383 6 0.0 1

SCHUMACHER LAURA J - Officer VICE CHAIRMAN

2021-12-21 17:21:11 -0500 2021-12-17 M 78,450 $54.86 d 0 direct

SCHUMACHER LAURA J - Officer VICE CHAIRMAN

2021-12-21 17:21:11 -0500 2021-12-17 M 78,450 $54.86 a 394,673 direct 0.7876 2.9383 2.9383 6 0.0 1

STEWART JEFFREY RYAN - Officer EVP, CHIEF COMMERCIAL OFFICER

2021-12-17 17:01:25 -0500 2021-12-15 S 2,152 $128.00 d 47,104 direct -0.6954 2.6975 2.7128 5 -0.6954 2

SORG ELAINE K. - Officer SVP, US COMMERCIAL OPERATIONS

2021-12-14 17:01:16 -0500 2021-12-13 S 3,229 $125.85 d 3,229 direct 1.1902 1.3975 1.3975 6 -0.5375 3

SORG ELAINE K. - Officer SVP, US COMMERCIAL OPERATIONS

2021-12-14 17:01:16 -0500 2021-12-13 S 3,229 $125.85 d 0 direct 1.1902 1.3975 1.3975 6 -0.5375 3

SORG ELAINE K. - Officer SVP, US COMMERCIAL OPERATIONS

2021-12-14 17:01:16 -0500 2021-12-10 F 5,137 $124.15 d 6,458 direct 1.1902 1.3975 1.3975 6 -0.5375 3

STEWART JEFFREY RYAN - Officer EVP, CHIEF COMMERCIAL OFFICER

2021-12-14 17:00:01 -0500 2021-12-10 F 1,713 $124.15 d 49,256 direct 1.1902 1.3975 1.3975 6 -0.5375 3

GONZALEZ RICHARD A - Director - Officer CHAIRMAN OF THE BOARD AND CEO

2021-12-10 17:02:05 -0500 2021-12-09 M 174,100 $61.36 a 550,697 direct 0.6166 3.4385 4.1657 4 0.0 1

GONZALEZ RICHARD A - Director - Officer CHAIRMAN OF THE BOARD AND CEO

2021-12-10 17:02:05 -0500 2021-12-09 M 174,100 $61.36 d 87,050 direct

GONZALEZ RICHARD A - Director - Officer CHAIRMAN OF THE BOARD AND CEO

2021-12-10 17:02:05 -0500 2021-12-09 S 109,624 $123.48 d 376,597 direct 0.6166 3.4385 4.1657 4 0.0 1

GONZALEZ RICHARD A - Director - Officer CHAIRMAN OF THE BOARD AND CEO

2021-12-10 17:02:05 -0500 2021-12-09 S 64,476 $122.80 d 486,221 direct 0.6166 3.4385 4.1657 4 0.0 1

RICHMOND TIMOTHY J. - Officer EVP, CHIEF HR OFFICER

2021-12-08 17:01:21 -0500 2021-12-06 M 50,350 $58.88 a 50,350 direct 1.0632 6.1458 6.1458 6 0.0 1

RICHMOND TIMOTHY J. - Officer EVP, CHIEF HR OFFICER

2021-12-08 17:01:21 -0500 2021-12-06 M 50,350 d 0 direct

RICHMOND TIMOTHY J. - Officer EVP, CHIEF HR OFFICER

2021-12-08 17:01:21 -0500 2021-12-06 S 50,350 $120.00 d 0 direct 1.0632 6.1458 6.1458 6 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ABBVIE INC ABBV 2022-01-19 22:15:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 21:45:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 21:15:04 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 20:45:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 20:15:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 19:45:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 19:15:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 18:45:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 18:15:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 17:45:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 17:15:04 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 16:45:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 16:15:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 15:45:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 15:15:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 14:45:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 14:15:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 13:45:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 13:15:03 UTC -0.18 0.25 0
ABBVIE INC ABBV 2022-01-19 12:45:03 UTC -0.18 0.25 0

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Highland Funds I- Highland Long/Short Equity Fund ABBV -6763.0 shares, $-515272.97 2020-03-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund ABBV -37.0 shares, $-3240.83 2020-09-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ABBV -40.0 shares, $-4314.8 2021-09-30 N-PORT
RUSSELL INVESTMENT CO- Sustainable Equity Fund ABBV -3639.0 shares, $-417284.13 2021-10-31 N-PORT
CLOUGH GLOBAL LONG/SHORT FUND- Clough Global Long/Short Fund ABBV -6370.0 shares, $-730447.9 2021-10-31 N-PORT
CLOUGH GLOBAL OPPORTUNITIES FUND- Clough Global Opportunities Fund ABBV -67050.0 shares, $-7688623.5 2021-10-31 N-PORT
CLOUGH GLOBAL EQUITY FUND- Clough Global Equity Fund ABBV -35430.0 shares, $-4062758.1 2021-10-31 N-PORT
CLOUGH GLOBAL DIVIDEND AND INCOME FUND- Clough Global Dividend and Income Fund ABBV -16390.0 shares, $-1879441.3 2021-10-31 N-PORT

Elevate your investments